BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ramaiah SK, Rittling S. Pathophysiological role of osteopontin in hepatic inflammation, toxicity, and cancer. Toxicol Sci. 2008;103:4-13. [PMID: 17890765 DOI: 10.1093/toxsci/kfm246] [Cited by in Crossref: 119] [Cited by in F6Publishing: 108] [Article Influence: 7.9] [Reference Citation Analysis]
Number Citing Articles
1 Ivanov SV, Ivanova AV, Goparaju CM, Chen Y, Beck A, Pass HI. Tumorigenic properties of alternative osteopontin isoforms in mesothelioma. Biochemical and Biophysical Research Communications 2009;382:514-8. [DOI: 10.1016/j.bbrc.2009.03.042] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
2 Pereira TA, Syn WK, Amâncio FF, Cunha PH, Caporali JF, Trindade GV, Santos ET, Souza MM, Andrade ZA, Witek RP, Secor WE, Pereira FE, Lambertucci JR, Diehl AM. Osteopontin Is Upregulated in Human and Murine Acute Schistosomiasis Mansoni. PLoS Negl Trop Dis 2016;10:e0005057. [PMID: 27755536 DOI: 10.1371/journal.pntd.0005057] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
3 Urtasun R, Lopategi A, George J, Leung TM, Lu Y, Wang X, Ge X, Fiel MI, Nieto N. Osteopontin, an oxidant stress sensitive cytokine, up-regulates collagen-I via integrin α(V)β(3) engagement and PI3K/pAkt/NFκB signaling. Hepatology. 2012;55:594-608. [PMID: 21953216 DOI: 10.1002/hep.24701] [Cited by in Crossref: 140] [Cited by in F6Publishing: 137] [Article Influence: 14.0] [Reference Citation Analysis]
4 Ingawale DK, Mandlik SK, Naik SR. Models of hepatotoxicity and the underlying cellular, biochemical and immunological mechanism(s): a critical discussion. Environ Toxicol Pharmacol. 2014;37:118-133. [PMID: 24322620 DOI: 10.1016/j.etap.2013.08.015] [Cited by in Crossref: 99] [Cited by in F6Publishing: 89] [Article Influence: 11.0] [Reference Citation Analysis]
5 Bruha R, Vitek L, Smid V. Osteopontin - A potential biomarker of advanced liver disease. Ann Hepatol 2020;19:344-52. [PMID: 32005637 DOI: 10.1016/j.aohep.2020.01.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
6 Zhao H, Chen Q, Alam A, Cui J, Suen KC, Soo AP, Eguchi S, Gu J, Ma D. The role of osteopontin in the progression of solid organ tumour. Cell Death Dis 2018;9:356. [PMID: 29500465 DOI: 10.1038/s41419-018-0391-6] [Cited by in Crossref: 94] [Cited by in F6Publishing: 88] [Article Influence: 23.5] [Reference Citation Analysis]
7 Ismail F, Mahmoud A, Abdelhaleem H, Mamdoh A, Geneidy M, Kamal E. Primary Sjögren's syndrome and B-non-Hodgkin lymphoma: role of CD4+ T lymphocytopenia. Rheumatol Int 2013;33:1021-5. [PMID: 22886469 DOI: 10.1007/s00296-012-2464-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
8 Cho H, Cho H, Kim H. Osteopontin: A multifunctional protein at the crossroads of inflammation, atherosclerosis, and vascular calcification. Curr Atheroscler Rep 2009;11:206-13. [DOI: 10.1007/s11883-009-0032-8] [Cited by in Crossref: 98] [Cited by in F6Publishing: 97] [Article Influence: 7.5] [Reference Citation Analysis]
9 Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136:215-233. [PMID: 19167326 DOI: 10.1016/j] [Cited by in F6Publishing: 153] [Reference Citation Analysis]
10 Yang JD, Nakamura I, Roberts LR. The tumor microenvironment in hepatocellular carcinoma: current status and therapeutic targets. Semin Cancer Biol 2011;21:35-43. [PMID: 20946957 DOI: 10.1016/j.semcancer.2010.10.007] [Cited by in Crossref: 216] [Cited by in F6Publishing: 207] [Article Influence: 18.0] [Reference Citation Analysis]
11 Kwak TK, Sohn EJ, Kim S, Won G, Choi JU, Jeong K, Jeong M, Kwon OS, Kim SH. Inhibitory effect of ethanol extract of Ocimum sanctum on osteopontin mediated metastasis of NCI-H460 non-small cell lung cancer cells. BMC Complement Altern Med 2014;14:419. [PMID: 25345853 DOI: 10.1186/1472-6882-14-419] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
12 Chuang CY, Chang H, Lin P, Sun SJ, Chen PH, Lin YY, Sheu GT, Ko JL, Hsu SL, Chang JT. Up-regulation of osteopontin expression by aryl hydrocarbon receptor via both ligand-dependent and ligand-independent pathways in lung cancer. Gene 2012;492:262-9. [PMID: 22037483 DOI: 10.1016/j.gene.2011.10.019] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
13 Schmitt A, Ehnert S, Schyschka L, Buschner P, Kühnl A, Döbele S, Siebenlist S, Lucke M, Stöckle U, Nussler AK. Monocytes do not transdifferentiate into proper osteoblasts. ScientificWorldJournal 2012;2012:384936. [PMID: 22623892 DOI: 10.1100/2012/384936] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
14 Su CM, Chiang YC, Huang CY, Hsu CJ, Fong YC, Tang CH. Osteopontin Promotes Oncostatin M Production in Human Osteoblasts: Implication of Rheumatoid Arthritis Therapy. J Immunol 2015;195:3355-64. [PMID: 26304992 DOI: 10.4049/jimmunol.1403191] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 4.6] [Reference Citation Analysis]
15 Yang H, Ye X, Zhang X, Li X, Fu Q, Tang Z. Intracellular osteopontin negatively regulates toll-like receptor 4-mediated inflammatory response via regulating GSK3β and 4EBP1 phosphorylation. Cytokine 2018;108:89-95. [PMID: 29587154 DOI: 10.1016/j.cyto.2018.03.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
16 Shi L, Wang X. Role of osteopontin in lung cancer evolution and heterogeneity. Semin Cell Dev Biol 2017;64:40-7. [PMID: 27578008 DOI: 10.1016/j.semcdb.2016.08.032] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
17 Haussler MR, Haussler CA, Whitfield GK, Hsieh JC, Thompson PD, Barthel TK, Bartik L, Egan JB, Wu Y, Kubicek JL, Lowmiller CL, Moffet EW, Forster RE, Jurutka PW. The nuclear vitamin D receptor controls the expression of genes encoding factors which feed the "Fountain of Youth" to mediate healthful aging. J Steroid Biochem Mol Biol 2010;121:88-97. [PMID: 20227497 DOI: 10.1016/j.jsbmb.2010.03.019] [Cited by in Crossref: 105] [Cited by in F6Publishing: 99] [Article Influence: 8.8] [Reference Citation Analysis]
18 Barikbin R, Neureiter D, Wirth J, Erhardt A, Schwinge D, Kluwe J, Schramm C, Tiegs G, Sass G. Induction of heme oxygenase 1 prevents progression of liver fibrosis in Mdr2 knockout mice. Hepatology 2012;55:553-62. [PMID: 21953613 DOI: 10.1002/hep.24711] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 3.8] [Reference Citation Analysis]
19 Zhang R, Pan X, Huang Z, Weber GF, Zhang G. Osteopontin enhances the expression and activity of MMP-2 via the SDF-1/CXCR4 axis in hepatocellular carcinoma cell lines. PLoS One. 2011;6:e23831. [PMID: 21909361 DOI: 10.1371/journal.pone.0023831] [Cited by in Crossref: 51] [Cited by in F6Publishing: 52] [Article Influence: 4.6] [Reference Citation Analysis]
20 Kaleta B, Boguska A. Sildenafil, a Phosphodiesterase Type 5 Inhibitor, Downregulates Osteopontin in Human Peripheral Blood Mononuclear Cells. Arch Immunol Ther Exp (Warsz) 2017;65:347-53. [PMID: 28210757 DOI: 10.1007/s00005-017-0455-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
21 He CY, Liang BB, Fan XY, Cao L, Chen R, Guo YJ, Zhao J. The dual role of osteopontin in acetaminophen hepatotoxicity. Acta Pharmacol Sin 2012;33:1004-12. [PMID: 22728710 DOI: 10.1038/aps.2012.47] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
22 Gómez-Santos B, Saenz de Urturi D, Nuñez-García M, Gonzalez-Romero F, Buque X, Aurrekoetxea I, Gutiérrez de Juan V, Gonzalez-Rellan MJ, García-Monzón C, González-Rodríguez Á, Mosteiro L, Errazti G, Mifsut P, Gaztambide S, Castaño L, Martin C, Nogueiras R, Martinez-Chantar ML, Syn WK, Aspichueta P. Liver osteopontin is required to prevent the progression of age-related nonalcoholic fatty liver disease. Aging Cell 2020;19:e13183. [PMID: 32638492 DOI: 10.1111/acel.13183] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
23 Banerjee A, Rose R, Johnson GA, Burghardt RC, Ramaiah SK. The Influence of Estrogen on Hepatobiliary Osteopontin (SPP1) Expression in a Female Rodent Model of Alcoholic Steatohepatitis. Toxicol Pathol 2009;37:492-501. [DOI: 10.1177/0192623309335633] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
24 Wang X, Cheng M, Zhao M, Ge A, Guo F, Zhang M, Yang Y, Liu L, Yang N. Differential effects of high-fat-diet rich in lard oil or soybean oil on osteopontin expression and inflammation of adipose tissue in diet-induced obese rats. Eur J Nutr 2013;52:1181-9. [PMID: 22847642 DOI: 10.1007/s00394-012-0428-z] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 3.9] [Reference Citation Analysis]
25 Kiefer FW, Zeyda M, Gollinger K, Pfau B, Neuhofer A, Weichhart T, Säemann MD, Geyeregger R, Schlederer M, Kenner L. Neutralization of osteopontin inhibits obesity-induced inflammation and insulin resistance. Diabetes. 2010;59:935-946. [PMID: 20107108 DOI: 10.2337/db09-0404] [Cited by in Crossref: 123] [Cited by in F6Publishing: 110] [Article Influence: 10.3] [Reference Citation Analysis]
26 Kaleta B. The role of osteopontin in kidney diseases. Inflamm Res 2019;68:93-102. [PMID: 30456594 DOI: 10.1007/s00011-018-1200-5] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 7.0] [Reference Citation Analysis]
27 Chen BL, Zhang GY, Wang SP, Li Q, Xu MH, Shen YM, Yan L, Gu H, Li J, Huang YL. The combined treatment of praziquantel with osteopontin immunoneutralization reduces liver damage in Schistosoma japonicum-infected mice. Parasitology. 2012;139:522-529. [PMID: 22309838 DOI: 10.1017/s0031182011002241] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
28 Fu Y, Zhang Y, Lei Z, Liu T, Cai T, Wang A, Du W, Zeng Y, Zhu J, Liu Z, Huang JA. Abnormally activated OPN/integrin αVβ3/FAK signalling is responsible for EGFR-TKI resistance in EGFR mutant non-small-cell lung cancer. J Hematol Oncol 2020;13:169. [PMID: 33287873 DOI: 10.1186/s13045-020-01009-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
29 da Costa AN, Plymoth A, Santos-Silva D, Ortiz-Cuaran S, Camey S, Guilloreau P, Sangrajrang S, Khuhaprema T, Mendy M, Lesi OA. Osteopontin and latent-TGF β binding-protein 2 as potential diagnostic markers for HBV-related hepatocellular carcinoma. Int J Cancer. 2015;136:172-181. [PMID: 24803312 DOI: 10.1002/ijc.28953] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 3.9] [Reference Citation Analysis]
30 Matsue Y, Tsutsumi M, Hayashi N, Saito T, Tsuchishima M, Toshikuni N. Serum Osteopontin predicts degree of hepatic fibrosis and serves as a biomarker in patients with hepatitis C virus infection. PLoS One. 2015;10:e0118744. [PMID: 25760884 DOI: 10.1371/journal.pone.0118744] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 5.0] [Reference Citation Analysis]
31 Yang M, Ramachandran A, Yan HM, Woolbright BL, Copple BL, Fickert P, Trauner M, Jaeschke H. Osteopontin is an initial mediator of inflammation and liver injury during obstructive cholestasis after bile duct ligation in mice. Toxicol Lett 2014;224:186-95. [PMID: 24188933 DOI: 10.1016/j.toxlet.2013.10.030] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 4.4] [Reference Citation Analysis]
32 Sanchez-Gonzalez C, Moreno L, Lopez-Chaves C, Nebot E, Pietschmann P, Rodriguez-Nogales A, Galvez J, Montes-Bayon M, Sanz-Medel A, Llopis J. Effect of vanadium on calcium homeostasis, osteopontin mRNA expression, and bone microarchitecture in diabetic rats. Metallomics 2017;9:258-67. [PMID: 28194470 DOI: 10.1039/c6mt00272b] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
33 Lee JH, Banerjee A, Ueno Y, Ramaiah SK. Potential relationship between hepatobiliary osteopontin and peroxisome proliferator-activated receptor alpha expression following ethanol-associated hepatic injury in vivo and in vitro. Toxicol Sci. 2008;106:290-299. [PMID: 18703563 DOI: 10.1093/toxsci/kfn165] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
34 Banerjee A, Lee JH, Ramaiah SK. Interaction of osteopontin with neutrophil alpha(4)beta(1) and alpha(9)beta(1) integrins in a rodent model of alcoholic liver disease. Toxicol Appl Pharmacol 2008;233:238-46. [PMID: 18778724 DOI: 10.1016/j.taap.2008.08.008] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
35 Fouad SA, Mohamed NA, Fawzy MW, Moustafa DA. Plasma Osteopontin Level in Chronic Liver Disease and Hepatocellular Carcinoma. Hepat Mon 2015;15:e30753. [PMID: 26500684 DOI: 10.5812/hepatmon.30753] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
36 Luna-Luna M, Medina-Urrutia A, Vargas-Alarcón G, Coss-Rovirosa F, Vargas-Barrón J, Pérez-Méndez Ó. Adipose Tissue in Metabolic Syndrome: Onset and Progression of Atherosclerosis. Arch Med Res 2015;46:392-407. [PMID: 26009250 DOI: 10.1016/j.arcmed.2015.05.007] [Cited by in Crossref: 60] [Cited by in F6Publishing: 53] [Article Influence: 8.6] [Reference Citation Analysis]
37 Kwon H, Song K, Han C, Chen W, Wang Y, Dash S, Lim K, Wu T. Inhibition of hedgehog signaling ameliorates hepatic inflammation in mice with nonalcoholic fatty liver disease. Hepatology. 2016;63:1155-1169. [PMID: 26473743 DOI: 10.1002/hep.28289] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 6.9] [Reference Citation Analysis]
38 Wang H, Chen L. Tumor microenviroment and hepatocellular carcinoma metastasis. J Gastroenterol Hepatol 2013;28 Suppl 1:43-8. [PMID: 23855295 DOI: 10.1111/jgh.12091] [Cited by in Crossref: 52] [Cited by in F6Publishing: 58] [Article Influence: 6.5] [Reference Citation Analysis]
39 Sun JY, Xu JM, Yan M, Ye F. Advances in understanding relationship between osteopontin and metastasis and recurrence of hepatocellular carcinoma. Shijie Huaren Xiaohua Zazhi 2013; 21(16): 1498-1504 [DOI: 10.11569/wcjd.v21.i16.1498] [Reference Citation Analysis]
40 Wen Y, Feng D, Wu H, Liu W, Li H, Wang F, Xia Q, Gao WQ, Kong X. Defective Initiation of Liver Regeneration in Osteopontin-Deficient Mice after Partial Hepatectomy due to Insufficient Activation of IL-6/Stat3 Pathway. Int J Biol Sci 2015;11:1236-47. [PMID: 26327817 DOI: 10.7150/ijbs.12118] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 4.7] [Reference Citation Analysis]
41 Srungaram P, Rule JA, Yuan HJ, Reimold A, Dahl B, Sanders C, Lee WM. Plasma osteopontin in acute liver failure. Cytokine. 2015;73:270-276. [PMID: 25802196 DOI: 10.1016/j.cyto.2015.02.021] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.9] [Reference Citation Analysis]
42 Rittling SR, Singh R. Osteopontin in Immune-mediated Diseases. J Dent Res 2015;94:1638-45. [PMID: 26341976 DOI: 10.1177/0022034515605270] [Cited by in Crossref: 74] [Cited by in F6Publishing: 69] [Article Influence: 10.6] [Reference Citation Analysis]
43 Perego S, Sansoni V, Ziemann E, Lombardi G. Another Weapon against Cancer and Metastasis: Physical-Activity-Dependent Effects on Adiposity and Adipokines. Int J Mol Sci 2021;22:2005. [PMID: 33670492 DOI: 10.3390/ijms22042005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
44 Bertino G, Ardiri A, Malaguarnera M, Malaguarnera G, Bertino N, Calvagno GS. Hepatocellualar carcinoma serum markers. Semin Oncol. 2012;39:410-433. [PMID: 22846859 DOI: 10.1053/j.seminoncol.2012.05.001] [Cited by in Crossref: 103] [Cited by in F6Publishing: 101] [Article Influence: 10.3] [Reference Citation Analysis]
45 Zhou Y, Mo S, Wang RH, Liu W, Liu J, Wang J, He J, Zhang H, Guan Z, Zhou S, Yu Y. Corn baked by burning coal triggered overexpression of osteopontin in hepatocytes of rats following fluorosis. Toxicol Ind Health 2012;28:195-202. [DOI: 10.1177/0748233711410905] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
46 Wang W, Li P, Li W, Jiang J, Cui Y, Li S, Wang Z. Osteopontin activates mesenchymal stem cells to repair skin wound. PLoS One 2017;12:e0185346. [PMID: 28957406 DOI: 10.1371/journal.pone.0185346] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
47 Aravalli RN, Steer CJ. Immune-Mediated Therapies for Liver Cancer. Genes (Basel) 2017;8:E76. [PMID: 28218682 DOI: 10.3390/genes8020076] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
48 Diao H, Liu X, Wu Z, Kang L, Cui G, Morimoto J, Denhardt DT, Rittling S, Iwakura Y, Uede T, Li L. Osteopontin regulates interleukin-17 production in hepatitis. Cytokine 2012;60:129-37. [PMID: 22818182 DOI: 10.1016/j.cyto.2012.06.287] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
49 Nuñez-Garcia M, Gomez-Santos B, Buqué X, García-Rodriguez JL, Romero MR, Marin JJG, Arteta B, García-Monzón C, Castaño L, Syn WK, Fresnedo O, Aspichueta P. Osteopontin regulates the cross-talk between phosphatidylcholine and cholesterol metabolism in mouse liver. J Lipid Res 2017;58:1903-15. [PMID: 28754826 DOI: 10.1194/jlr.M078980] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
50 Wolosz D, Walczak A, Wilczynski GM, Szparecki G, Wilczek E, Gornicka B. Deleted in liver cancer 1 expression and localization in hepatocellular carcinoma tissue sections. Oncol Lett 2014;8:785-8. [PMID: 25013499 DOI: 10.3892/ol.2014.2216] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
51 Liu YJ, Zhang DQ, Sui XM, Tian W. Overexpression of human osteopontin increases cell proliferation and migration in human embryo kidney-293 cells. Cell Mol Biol Lett 2009;14:670-8. [PMID: 19562270 DOI: 10.2478/s11658-009-0027-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
52 He C, Fan X, Chen R, Liang B, Cao L, Guo Y, Zhao J. Osteopontin is involved in estrogen-mediated protection against diethylnitrosamine-induced liver injury in mice. Food Chem Toxicol 2012;50:2878-85. [PMID: 22609492 DOI: 10.1016/j.fct.2012.05.012] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
53 Fujisawa K, Yabuuchi C, Izawa T, Kuwamura M, Takasu N, Torii M, Yamate J. Expression patterns of heat shock protein 25 in carbon tetrachloride-induced rat liver injury. Experimental and Toxicologic Pathology 2013;65:469-76. [DOI: 10.1016/j.etp.2012.02.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
54 Dong H, Xiang S, Liang H, Li C, Zhang Z, Chen X. The niche of hepatic cancer stem cell and cancer recurrence. Medical Hypotheses 2013;80:666-8. [DOI: 10.1016/j.mehy.2013.01.021] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
55 Neuman MG. Biomarkers of Drug-Induced Liver Toxicity. Ther Drug Monit 2019;41:227-34. [PMID: 30883515 DOI: 10.1097/FTD.0000000000000610] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.7] [Reference Citation Analysis]
56 Zhang X, You X, Wang Q, Zhang T, Du Y, Lv N, Zhang Z, Zhang S, Shan C, Ye L. Hepatitis B virus X protein drives multiple cross-talk cascade loops involving NF-κB, 5-LOX, OPN and Capn4 to promote cell migration. PLoS One. 2012;7:e31458. [PMID: 22355367 DOI: 10.1371/journal.pone.0031458] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
57 Khajehahmadi Z, Mohagheghi S, Nikeghbalian S, Geramizadeh B, Khodadadi I, Karimi J, Tavilani H. Liver stiffness correlates with serum osteopontin and TAZ expression in human liver cirrhosis. Ann N Y Acad Sci 2020;1465:117-31. [PMID: 31696937 DOI: 10.1111/nyas.14259] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
58 Tang M, Dai W, Wu H, Xu X, Jiang B, Wei Y, Qian H, Han L. Transcriptome analysis of tongue cancer based on high‑throughput sequencing. Oncol Rep 2020;43:2004-16. [PMID: 32236620 DOI: 10.3892/or.2020.7560] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
59 Froehlich JW, Chu CS, Tang N, Waddell K, Grimm R, Lebrilla CB. Label-free liquid chromatography-tandem mass spectrometry analysis with automated phosphopeptide enrichment reveals dynamic human milk protein phosphorylation during lactation. Anal Biochem 2011;408:136-46. [PMID: 20804719 DOI: 10.1016/j.ab.2010.08.031] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
60 Roth SE, Avigan MI, Bourdet D, Brott D, Church R, Dash A, Keller D, Sherratt P, Watkins PB, Westcott-Baker L, Lentini S, Merz M, Ramaiah L, Ramaiah SK, Stanley AM, Marcinak J. Next-Generation DILI Biomarkers: Prioritization of Biomarkers for Qualification and Best Practices for Biospecimen Collection in Drug Development. Clin Pharmacol Ther 2020;107:333-46. [PMID: 31314926 DOI: 10.1002/cpt.1571] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
61 Bruha R, Jachymova M, Petrtyl J, Dvorak K, Lenicek M, Urbanek P, Svestka T, Vitek L. Osteopontin: A non-invasive parameter of portal hypertension and prognostic marker of cirrhosis. World J Gastroenterol 2016; 22(12): 3441-3450 [PMID: 27022226 DOI: 10.3748/wjg.v22.i12.3441] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
62 Patouraux S, Bonnafous S, Voican CS, Anty R, Saint-Paul MC, Rosenthal-Allieri MA, Agostini H, Njike M, Barri-Ova N, Naveau S, Le Marchand-Brustel Y, Veillon P, Calès P, Perlemuter G, Tran A, Gual P. The osteopontin level in liver, adipose tissue and serum is correlated with fibrosis in patients with alcoholic liver disease. PLoS One 2012;7:e35612. [PMID: 22530059 DOI: 10.1371/journal.pone.0035612] [Cited by in Crossref: 58] [Cited by in F6Publishing: 51] [Article Influence: 5.8] [Reference Citation Analysis]
63 Gionfra F, De Vito P, Pallottini V, Lin HY, Davis PJ, Pedersen JZ, Incerpi S. The Role of Thyroid Hormones in Hepatocyte Proliferation and Liver Cancer. Front Endocrinol (Lausanne) 2019;10:532. [PMID: 31543862 DOI: 10.3389/fendo.2019.00532] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
64 Metivier KS, Deitz K, Xu WW, Conzemius M, Wilke VL. Gene expression profiling demonstrates differential expression of osteopontin in follicular thyroid carcinomas compared to normal thyroid tissue in dogs: Osteopontin expression in canine thyroid carcinoma. Vet Comp Oncol 2014;12:181-97. [DOI: 10.1111/j.1476-5829.2012.00348.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
65 Nabih MI, Aref WM, Fathy MM. Significance of plasma osteopontin in diagnosis of hepatitis C virus-related hepatocellular carcinoma. Arab J Gastroenterol. 2014;15:103-107. [PMID: 25249230 DOI: 10.1016/j.ajg.2014.08.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
66 Li JJ, Li HY, Gu F. Diagnostic significance of serum osteopontin level for pancreatic cancer: a meta-analysis. Genet Test Mol Biomarkers. 2014;18:580-586. [PMID: 24950303 DOI: 10.1089/gtmb.2014.0102] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
67 Komatsu Y, Waku T, Iwasaki N, Ono W, Yamaguchi C, Yanagisawa J. Global analysis of DNA methylation in early-stage liver fibrosis. BMC Med Genomics. 2012;5:5. [PMID: 22281153 DOI: 10.1186/1755-8794-5-5] [Cited by in Crossref: 60] [Cited by in F6Publishing: 62] [Article Influence: 6.0] [Reference Citation Analysis]
68 Woolbright BL, Jaeschke H. Therapeutic targets for cholestatic liver injury. Expert Opin Ther Targets 2016;20:463-75. [PMID: 26479335 DOI: 10.1517/14728222.2016.1103735] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 4.1] [Reference Citation Analysis]
69 Voican CS, Perlemuter G, Naveau S. Mechanisms of the inflammatory reaction implicated in alcoholic hepatitis: 2011 update. Clin Res Hepatol Gastroenterol. 2011;35:465-474. [PMID: 21571602 DOI: 10.1016/j.clinre.2011.01.017] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
70 Yun S, Lee D, Kang S, Kim DW, Kim Y, Cho JY, Seo K. Proteomic analysis of aqueous humor in canine primary angle-closure glaucoma in American Cocker Spaniel dogs. Vet Ophthalmol 2021;24:520-32. [PMID: 34558166 DOI: 10.1111/vop.12937] [Reference Citation Analysis]
71 Liu L, Luo Q, Sun J, Wang A, Shi Y, Ju Y, Morita Y, Song G. Decreased nuclear stiffness via FAK-ERK1/2 signaling is necessary for osteopontin-promoted migration of bone marrow-derived mesenchymal stem cells. Exp Cell Res 2017;355:172-81. [PMID: 28392353 DOI: 10.1016/j.yexcr.2017.04.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
72 Hu C, Li L. Improvement of mesenchymal stromal cells and their derivatives for treating acute liver failure. J Mol Med 2019;97:1065-84. [DOI: 10.1007/s00109-019-01804-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
73 Zhao M, Zang B, Cheng M, Ma Y, Yang Y, Yang N. Differential responses of hepatic endoplasmic reticulum stress and inflammation in diet-induced obese rats with high-fat diet rich in lard oil or soybean oil. PLoS One 2013;8:e78620. [PMID: 24223162 DOI: 10.1371/journal.pone.0078620] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
74 Kiefer FW, Neschen S, Pfau B, Legerer B, Neuhofer A, Kahle M, Hrabé de Angelis M, Schlederer M, Mair M, Kenner L, Plutzky J, Zeyda M, Stulnig TM. Osteopontin deficiency protects against obesity-induced hepatic steatosis and attenuates glucose production in mice. Diabetologia 2011;54:2132-42. [PMID: 21562757 DOI: 10.1007/s00125-011-2170-0] [Cited by in Crossref: 59] [Cited by in F6Publishing: 56] [Article Influence: 5.4] [Reference Citation Analysis]
75 Damsongsang P, Chaikiawkeaw D, Phoolcharoen W, Rattanapisit K, Kaewpungsup P, Pavasant P, Hoven VP. Surface-immobilized plant-derived osteopontin as an effective platform to promote osteoblast adhesion and differentiation. Colloids Surf B Biointerfaces 2019;173:816-24. [PMID: 30551297 DOI: 10.1016/j.colsurfb.2018.10.032] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
76 Vairo F, Sperb-Ludwig F, Wilke M, Michellin-Tirelli K, Netto C, Neto EC, Schwartz I. Osteopontin: a potential biomarker of Gaucher disease. Ann Hematol 2015;94:1119-25. [PMID: 25875742 DOI: 10.1007/s00277-015-2354-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
77 Iida T, Wagatsuma K, Hirayama D, Nakase H. Is Osteopontin a Friend or Foe of Cell Apoptosis in Inflammatory Gastrointestinal and Liver Diseases? Int J Mol Sci 2017;19:E7. [PMID: 29267211 DOI: 10.3390/ijms19010007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
78 Fang X, Wang R, Ma J, Ding Y, Shang W, Sun Z. Ameliorated ConA-induced hepatitis in the absence of PKC-theta. PLoS One 2012;7:e31174. [PMID: 22347449 DOI: 10.1371/journal.pone.0031174] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
79 Aravalli RN, Cressman EN, Steer CJ. Cellular and molecular mechanisms of hepatocellular carcinoma: an update. Arch Toxicol. 2013;87:227-247. [PMID: 23007558 DOI: 10.1007/s00204-012-0931-2] [Cited by in Crossref: 136] [Cited by in F6Publishing: 137] [Article Influence: 13.6] [Reference Citation Analysis]
80 Pereira TA, Syn WK, Machado MV, Vidigal PV, Resende V, Voieta I, Xie G, Otoni A, Souza MM, Santos ET. Schistosome-induced cholangiocyte proliferation and osteopontin secretion correlate with fibrosis and portal hypertension in human and murine schistosomiasis mansoni. Clin Sci (Lond). 2015;129:875-883. [PMID: 26201095 DOI: 10.1042/cs20150117] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.9] [Reference Citation Analysis]
81 Rittling SR. Osteopontin in macrophage function. Expert Rev Mol Med 2011;13:e15. [PMID: 21545755 DOI: 10.1017/S1462399411001839] [Cited by in Crossref: 67] [Cited by in F6Publishing: 42] [Article Influence: 6.1] [Reference Citation Analysis]
82 Osna NA, Ganesan M, Seth D, Wyatt TA, Kidambi S, Kharbanda KK. Second hits exacerbate alcohol-related organ damage: an update. Alcohol Alcohol 2021;56:8-16. [PMID: 32869059 DOI: 10.1093/alcalc/agaa085] [Reference Citation Analysis]
83 Tampaki M, Doumba PP, Deutsch M, Koskinas J. Circulating biomarkers of hepatocellular carcinoma response after locoregional treatments: New insights. World J Hepatol 2015; 7(14): 1834-1842 [PMID: 26207165 DOI: 10.4254/wjh.v7.i14.1834] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
84 Rittling SR, Zetterberg C, Yagiz K, Skinner S, Suzuki N, Fujimura A, Sasaki H. Protective role of osteopontin in endodontic infection. Immunology 2010;129:105-14. [PMID: 19824920 DOI: 10.1111/j.1365-2567.2009.03159.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
85 Capece D, Fischietti M, Verzella D, Gaggiano A, Cicciarelli G, Tessitore A, Zazzeroni F, Alesse E. The inflammatory microenvironment in hepatocellular carcinoma: a pivotal role for tumor-associated macrophages. Biomed Res Int. 2013;2013:187204. [PMID: 23533994 DOI: 10.1155/2013/187204] [Cited by in Crossref: 209] [Cited by in F6Publishing: 201] [Article Influence: 20.9] [Reference Citation Analysis]
86 Kaleta B. Role of osteopontin in systemic lupus erythematosus. Arch Immunol Ther Exp (Warsz) 2014;62:475-82. [PMID: 24917428 DOI: 10.1007/s00005-014-0294-x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 3.0] [Reference Citation Analysis]
87 Uede T. Osteopontin, intrinsic tissue regulator of intractable inflammatory diseases. Pathol Int. 2011;61:265-280. [PMID: 21501293 DOI: 10.1111/j.1440-1827.2011.02649.x] [Cited by in Crossref: 116] [Cited by in F6Publishing: 116] [Article Influence: 10.5] [Reference Citation Analysis]
88 Fujisawa K, Miyoshi T, Tonomura Y, Izawa T, Kuwamura M, Torii M, Yamate J. Relationship of heat shock protein 25 with reactive macrophages in thioacetamide-induced rat liver injury. Experimental and Toxicologic Pathology 2011;63:599-605. [DOI: 10.1016/j.etp.2010.04.014] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
89 Moreno-Viedma V, Tardelli M, Zeyda M, Sibilia M, Burks JD, Stulnig TM. Osteopontin-deficient progenitor cells display enhanced differentiation to adipocytes. Obes Res Clin Pract 2018;12:277-85. [PMID: 29519755 DOI: 10.1016/j.orcp.2018.02.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
90 Monson MS, Settlage RE, McMahon KW, Mendoza KM, Rawal S, El-Nezami HS, Coulombe RA, Reed KM. Response of the hepatic transcriptome to aflatoxin B1 in domestic turkey (Meleagris gallopavo). PLoS One 2014;9:e100930. [PMID: 24979717 DOI: 10.1371/journal.pone.0100930] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
91 Wang KX, Denhardt DT. Osteopontin: role in immune regulation and stress responses. Cytokine Growth Factor Rev. 2008;19:333-345. [PMID: 18952487 DOI: 10.1016/j.cytogfr.2008.08.001] [Cited by in Crossref: 439] [Cited by in F6Publishing: 424] [Article Influence: 31.4] [Reference Citation Analysis]
92 Slany A, Haudek VJ, Zwickl H, Gundacker NC, Grusch M, Weiss TS, Seir K, Rodgarkia-Dara C, Hellerbrand C, Gerner C. Cell characterization by proteome profiling applied to primary hepatocytes and hepatocyte cell lines Hep-G2 and Hep-3B. J Proteome Res 2010;9:6-21. [PMID: 19678649 DOI: 10.1021/pr900057t] [Cited by in Crossref: 67] [Cited by in F6Publishing: 69] [Article Influence: 5.6] [Reference Citation Analysis]
93 Cabiati M, Gaggini M, Cesare MM, Caselli C, De Simone P, Filipponi F, Basta G, Gastaldelli A, Del Ry S. Osteopontin in hepatocellular carcinoma: A possible biomarker for diagnosis and follow-up. Cytokine 2017;99:59-65. [PMID: 28711012 DOI: 10.1016/j.cyto.2017.07.004] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
94 Dolin CE, Arteel GE. The Matrisome, Inflammation, and Liver Disease. Semin Liver Dis 2020;40:180-8. [PMID: 31910448 DOI: 10.1055/s-0039-3402516] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
95 Qin LX. Inflammatory immune responses in tumor microenvironment and metastasis of hepatocellular carcinoma. Cancer Microenviron. 2012;5:203-209. [PMID: 22678823 DOI: 10.1007/s12307-012-0111-1] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 4.0] [Reference Citation Analysis]
96 Mirzaei A, Mohammadi S, Ghaffari SH, Yaghmaie M, Vaezi M, Alimoghaddam K, Ghavamzadeh A. Osteopontin b and c Splice isoforms in Leukemias and Solid Tumors: Angiogenesis Alongside Chemoresistance. Asian Pac J Cancer Prev 2018;19:615-23. [PMID: 29580029 DOI: 10.22034/APJCP.2018.19.3.615] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
97 Atai NA, Bansal M, Lo C, Bosman J, Tigchelaar W, Bosch KS, Jonker A, De Witt Hamer PC, Troost D, McCulloch CA, Everts V, Van Noorden CJ, Sodek J. Osteopontin is up-regulated and associated with neutrophil and macrophage infiltration in glioblastoma. Immunology 2011;132:39-48. [PMID: 20722758 DOI: 10.1111/j.1365-2567.2010.03335.x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 55] [Article Influence: 4.8] [Reference Citation Analysis]
98 Li M, Cai SY, Boyer JL. Mechanisms of bile acid mediated inflammation in the liver. Mol Aspects Med. 2017;56:45-53. [PMID: 28606651 DOI: 10.1016/j.mam.2017.06.001] [Cited by in Crossref: 80] [Cited by in F6Publishing: 76] [Article Influence: 16.0] [Reference Citation Analysis]
99 Aravalli RN. Role of innate immunity in the development of hepatocellular carcinoma. World J Gastroenterol 2013; 19(43): 7500-7514 [PMID: 24282342 DOI: 10.3748/wjg.v19.i43.7500] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 33] [Article Influence: 3.9] [Reference Citation Analysis]
100 Zhou C, Zhou HJ, Zhang XF, Lou LL, Ye QH, Zheng Y, Wang J, Zhu HT, Dong QZ, Jia HL, Zhu WW, Guo L, Zhao Y, Gao DM, Qin LX. Postoperative serum osteopontin level is a novel monitor for treatment response and tumor recurrence after resection of hepatitis B-related hepatocellular carcinoma. Ann Surg Oncol 2013;20:929-37. [PMID: 23203407 DOI: 10.1245/s10434-012-2749-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
101 Kullak-Ublick GA, Andrade RJ, Merz M, End P, Benesic A, Gerbes AL, Aithal GP. Drug-induced liver injury: recent advances in diagnosis and risk assessment. Gut 2017;66:1154-64. [PMID: 28341748 DOI: 10.1136/gutjnl-2016-313369] [Cited by in Crossref: 196] [Cited by in F6Publishing: 176] [Article Influence: 39.2] [Reference Citation Analysis]
102 Kaleta B, Mróz P, Górski A, Łukaszkiewicz J, Woźniacka A, Bogaczewicz J. The preliminary association study of osteopontin 707 C/T polymorphism with systemic lupus erythematosus in a Polish population. Postepy Dermatol Alergol 2020;37:190-4. [PMID: 32489353 DOI: 10.5114/ada.2019.83499] [Reference Citation Analysis]
103 Dadarkar SS, Fonseca LC, Mishra PB, Lobo AS, Doshi LS, Dagia NM, Rangasamy AK, Padigaru M. Phenotypic and genotypic assessment of concomitant drug-induced toxic effects in liver, kidney and blood. J Appl Toxicol 2011;31:117-30. [PMID: 20623750 DOI: 10.1002/jat.1562] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
104 Wang T, Hu HS, Feng YX, Shi J, Li N, Guo WX, Xue J, Xie D, Liu SR, Wu MC, Cheng SQ. Characterisation of a novel cell line (CSQT-2) with high metastatic activity derived from portal vein tumour thrombus of hepatocellular carcinoma. Br J Cancer 2010;102:1618-26. [PMID: 20461085 DOI: 10.1038/sj.bjc.6605689] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 3.4] [Reference Citation Analysis]
105 Fasano R, Shadbad MA, Brunetti O, Argentiero A, Calabrese A, Nardulli P, Calbi R, Baradaran B, Silvestris N. Immunotherapy for Hepatocellular Carcinoma: New Prospects for the Cancer Therapy. Life (Basel) 2021;11:1355. [PMID: 34947886 DOI: 10.3390/life11121355] [Reference Citation Analysis]
106 Ge T, Shen Q, Wang N, Zhang Y, Ge Z, Chu W, Lv X, Zhao F, Zhao W, Fan J, Qin W. Diagnostic values of alpha-fetoprotein, dickkopf-1, and osteopontin for hepatocellular carcinoma. Med Oncol 2015;32. [DOI: 10.1007/s12032-014-0367-z] [Cited by in Crossref: 31] [Cited by in F6Publishing: 35] [Article Influence: 4.4] [Reference Citation Analysis]
107 Shirasaki T, Honda M, Yamashita T, Nio K, Shimakami T, Shimizu R, Nakasyo S, Murai K, Shirasaki N, Okada H, Sakai Y, Sato T, Suzuki T, Yoshioka K, Kaneko S. The osteopontin-CD44 axis in hepatic cancer stem cells regulates IFN signaling and HCV replication. Sci Rep 2018;8:13143. [PMID: 30177680 DOI: 10.1038/s41598-018-31421-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
108 Zhao F, Zhang Y, Wang H, Jin M, He S, Shi Y, Guo Y, Zhang Y. Blockade of osteopontin reduces alloreactive CD8+ T cell-mediated graft-versus-host disease. Blood 2011;117:1723-33. [PMID: 21119110 DOI: 10.1182/blood-2010-04-281659] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
109 Adams DH, Ju C, Ramaiah SK, Uetrecht J, Jaeschke H. Mechanisms of immune-mediated liver injury. Toxicol Sci. 2010;115:307-321. [PMID: 20071422 DOI: 10.1093/toxsci/kfq009] [Cited by in Crossref: 201] [Cited by in F6Publishing: 177] [Article Influence: 16.8] [Reference Citation Analysis]